CALR-Apr-2014

Text Size

Share this page on any of these social networking sites:
Share this page on any of these social networking sites: LinkedIn

 

Law Reporter Products

  • Abstract Sets
  • Court Documents
  • Injury Collections

Get More Info »

Search the Exchange »

April 2014

Case in Point

Drugmaker did not disclose quality control problems to investors

The investors filed class actions against the drugmaker and others, alleging the defendants issued misstatements and failed to disclose material facts in violation of Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The defendants settled for $12.8 million. Pub. Pension Fund Group v. KV Pharm. Co.

 

The American Association for Justice
777 6th Street, NW, Ste 200 • Washington, DC  20001 • 800.424.2725 or 202.965.3500

© 2014 AAJ